Basic Information
Basic information for LINC01278-226-21aa-2
Peptide Name LINC01278-226-21aa-2
Genome Position chrX:63427209-63427271[-]
Species Human
Peptide Sequence MTGLQSFDIKSLTPGGKDHPF
Peptide Length 21
Unique No (LINC01278-202-21aa-2,LINC01278-204-21aa,LINC01278-205-21aa-2,LINC01278-209-21aa-2,LINC01278-213-21aa,LINC01278-219-21aa-1,LINC01278-235-21aa-2,LINC01278-238-21aa-2)
Grand Average of Hydropathicity -0.4429
Relative Molecular Mass 2636.96
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000665925;LINC01278-226
Transcript Length 1847
Coding Ability 0.3942
DNA Sequence Corresponding to Peptide ATGACAGGGCTGCAGAGCTTTGACATCAAGTCGCTGACTCCTGGTGGCAAGGATCATCCCTTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :